Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 325 clinical trials
Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma

The investigators propose a phase II randomized-controlled study on using durvalumab in combination with induction chemotherapy followed by concurrent chemoradiation and adjuvant durvalumab, compared to induction chemotherapy followed by concurrent chemoradiation for previously untreated locoregionally advanced stage III to IVA NPC. In parallel, the investigators will also perform collateral tumor …

hysterectomy
neuropathy
formalin-fixed paraffin-embedded
follicle stimulating hormone
concurrent chemoradiation
  • 0 views
  • 05 Aug, 2020
Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants

The aim of the project is to study the effects of fortification (using a Human Milk Donor Fortifier) of an exclusive preterm human milk diet on outcome of extremely preterm neonates, born at less or equal to 27 weeks.

enteral feeding
  • 0 views
  • 16 Feb, 2024
  • 1 location
PCOS Treatment Using DLBS3233, Metformin, and Combination of Both (POSITIF)  

This is a 3-arm, randomized, double-blind, double-dummy, and controlled clinical study over 6 months of treatment to evaluate the metabolic and clinical efficacy as well as the safety of DLBS3233 alone, metformin and combination of both, in improving metabolic and reproductive parameters.

  • 0 views
  • 26 Oct, 2022
  • 4 locations
Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare

The purpose of this study is to determine whether personnel and patients/clients in healthcare in Region Stockholm have a currrent SARS-CoV-2 infection or have had an infection. This information will be used to understand how the infection spreads in healthcare, to explore the association with sick-leave among personnel, and to …

throat
acute respiratory syndrome (sars)
SARS
  • 0 views
  • 01 Feb, 2023
  • 1 location
Epidemiologic Clinical Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection

The study cohort will be enrolled among all Humanitas group employees (including ICH, Humanitas University and Gavazzeni), and two validation cohorts. Participants will be asked consent for the research use of blood, pharyngeal swab, and for those hospitalized for COVID-19, also for the bronchoalveolar lavage and fecal samples. Biological samples …

covid-19
bronchoalveolar lavage
  • 0 views
  • 16 Feb, 2024
  • 1 location
French COVID Cohort

Infectious disease is the single biggest cause of death worldwide. New infectious agents, such as the SARS, MERS and other novel coronavirus, novel influenza viruses, viruses causing viral haemorrhagic fever (e.g. Ebola), and viruses that affect the central nervous system (CNS) such as TBEV & Nipah require investigation to understand …

antibiotics
influenza
acute respiratory syndrome (sars)
coronavirus infection
mers
  • 0 views
  • 16 Feb, 2024
  • 81 locations
C-reactive Protein Levels Among Individuals With COVID-19

The primary objective of this multi-center study is to clarify the value of a CRP measurement for triage of patients initially presenting with light symptoms of the COVID-19 infection. Current recommendations of management of COVID-19 include large-scale tests for virus. Such tests reveal whether an individual is infected with the …

covid-19
oxygen saturation
blood test
  • 0 views
  • 16 Feb, 2024
  • 1 location
Understanding Immunity to SARS-CoV-2 the Coronavirus Causing COVID-19

The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

coronavirus infection
acute respiratory syndrome (sars)
covid-19
pneumonia
SARS
  • 0 views
  • 16 Feb, 2024
  • 1 location
Insight Into the UAE Experience With Monoclonal Antibodies (Sotrovimab ) (EHS-Strategy)

Sotrovimab is a newly developed monoclonal antibody for the treatment of mild and moderate COVID-19 patient, who are at high risk for progression to severe COVID-19, including hospitalization or death. This includes, for example, individuals who are 65 years of age and older or individuals who have certain medical conditions. …

  • 0 views
  • 07 Dec, 2021
  • 1 location
COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses

The study is to investigate the antibody response in the blood and saliva of people with a known COVID-19 infection in the canton of Baselland.

antibody test
covid-19
acute respiratory syndrome (sars)
SARS
  • 0 views
  • 16 Feb, 2024
  • 1 location